Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
TESARO, Inc.
4237
TESARO, Inc.
Health Care
Technology
Biotechnology
TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.
Suggest edits
Founded
2010
Raised
$366M
Follow us
Companies in the same industry
Calhoun Vision, Inc.
Metis Precision Medicine
Monarch Biosciences
FoRx Therapeutics
Pincell
Pneumagen
Lepu Bio
Hyperion Therapeutics, Inc
AZTherapies
Kinaset Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
18 Apr
2016
$50,000,000
Post-IPO equity
SEC FORM D
sec
10 Mar
2016
$155,000,000
Post-IPO equity
SEC FORM D
sec
21 Jun
2011
$101,000,000
Venture capital (Series B)
InterWest Partners
,
Kleiner Perkins Caufield & Byers
,
Pappas Ventures
,
+2
28 May
2010
$60,000,000
Venture capital (Series A)
NEA
